Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Publication year range
1.
Nanotechnology ; 27(25): 255602, 2016 Jun 24.
Article in English | MEDLINE | ID: mdl-27171728

ABSTRACT

Colloidal suspensions of oxocarbon-encapsulated gold nanoparticles have been synthesized in a one-step procedure by pulsed-laser ablation (PLA) at 532 nm of a solid gold target placed in aqueous solution containing CO2 absorbers, but without any stabilizing agent. Multi-wavelength surface enhanced Raman spectroscopy allows the identification of adsorbed amorphous carbon and graphite, Au-carbonyl, Au coordinated CO2-derived bicarbonates/carbonates and hydroxyl groups around the AuNPs core. Scanning electron microscopy, energy dispersive x-ray analysis and high resolution transmission electron microscopy highlight the organic shell structure around the crystalline metal core. The stability of the colloidal solution of nanocomposites (NCs) seems to be driven by solvation forces and is achieved only in neutral or basic pH using monovalent hydroxide counter-ions (NaOH, KOH). The NCs are characterized by a blue shift of the localized surface plasmon resonance (LSPR) band typical of metal-ligand stabilization by terminal π-back bonding, attributed to a core charging effect caused by Au-carbonyls. Total organic carbon measurements detect the final content of organic carbon in the colloidal solution of NCs that is about six times higher than the value of the water solution used to perform PLA. The colloidal dispersions of NCs are stable for months and are applied as analytical probes in amino glycoside antibiotic LSPR based sensing.

2.
Metallomics ; 7(5): 743-7, 2015 May.
Article in English | MEDLINE | ID: mdl-25860559

ABSTRACT

Disruptions of biometal-Aß(1-40) interactions by an isoniazid-derived hydrazone, INHHQ, were demonstrated via in vitro NMR titrations. The compound has adequate theoretical BBB absorption properties, assessed by in silico studies. In vivo acute toxicity assays indicate that INHHQ is innocuous up to 300 mg kg(-1), showing potential as an anti-Alzheimer's drug.


Subject(s)
Amyloid beta-Peptides/metabolism , Copper/metabolism , Hydrazones/chemistry , Hydrazones/pharmacology , Isoniazid/analogs & derivatives , Isoniazid/pharmacology , Peptide Fragments/metabolism , Zinc/metabolism , Alzheimer Disease/drug therapy , Animals , Blood-Brain Barrier/metabolism , Homeostasis/drug effects , Humans , Hydrazones/pharmacokinetics , Isoniazid/pharmacokinetics , Male , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL